Related Experiment Video
Updated: Aug 6, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Methoxyflurane as an analgesic and sedative agent in oral and maxillofacial surgery: a scoping review
Bernardo Correia Lima1, Pedro Américo Felizardo Dos Santos2, Michelle Alonso Coutinho3
1Department of Oral and Maxillofacial Surgery, Traumatology and Prosthesis, Dental School of University of São Paulo, São Paulo SP, Brazil.
Introduction:
Methoxyflurane (MOF) is a low-dose inhaled analgesic with rapid onset, patient-controlled titration, and an established safety profile at sub-anesthetic doses. Its potential role in oral and maxillofacial surgery (OMFS) has not been comprehensively mapped.
Objective:
To map and characterize available evidence on inhaled methoxyflurane in OMFS, including dento-alveolar surgery, acute oral pain emergencies, and outpatient analgesic-sedation.
Methods:
Scoping review conducted following JBI methodology and reported per PRISMA-ScR. Eligibility defined by PCC (Population, Concept, Context) framework. Searched: MEDLINE (PubMed), Embase, Cochrane CENTRAL, Scopus, and Web of Science, with no date restriction. Two independent reviewers screened records; data charted using a standardised form.
Results:
Twenty studies were identified: 10 with direct OMFS/dental relevance (2 RCTs, 2 case series, 1 clinical study, 2 narrative reviews, 1 systematic review, 1 feasibility review, 1 ongoing Phase 3 RCT) and 10 with indirect but clinically translatable relevance. MOF demonstrated comparable sedation and greater patient preference versus nitrous oxide in third molar surgery (p < 0.05). Systematic reviews in outpatient procedural contexts reported satisfaction rates of 63%->98% and no serious adverse events at analgesic doses. The pivotal METODO trial (NCT06495372), a Phase 3 placebo-controlled RCT in adult dental emergencies, is currently enrolling (expected completion October 2026).
Conclusion:
Available evidence supports the clinical feasibility of MOF in OMFS, particularly for third molar surgery and acute oral pain. High-quality OMFS-specific RCTs remain lacking. The METODO trial will provide pivotal data to guide practice. Future research should address OMFS-specific protocols and jurisdictions where MOF lacks regulatory approval.
Insights
Low-dose methoxyflurane (MOF) shows promise for oral and maxillofacial surgery (OMFS), offering effective pain relief and sedation. Further high-quality trials are needed to confirm its role in OMFS procedures and acute oral pain management.
Area of Science:
- Anesthesiology
- Oral and Maxillofacial Surgery
- Pain Management
Background:
- Methoxyflurane (MOF) is a low-dose inhaled analgesic with rapid onset and patient-controlled titration.
- Its safety profile at sub-anesthetic doses is established, but its application in oral and maxillofacial surgery (OMFS) requires comprehensive mapping.
- Current evidence on MOF in OMFS is limited, necessitating a review of available data.
Purpose of the Study:
- To map and characterize existing evidence on the use of inhaled methoxyflurane in OMFS.
- To evaluate MOF's efficacy in dento-alveolar surgery, acute oral pain emergencies, and outpatient analgesic-sedation.
- To identify gaps in the literature and guide future research directions.
Main Methods:
- A scoping review was conducted following JBI methodology and reported per PRISMA-ScR guidelines.
- Eligibility criteria were defined using the PCC (Population, Concept, Context) framework.
- Extensive literature searches were performed across multiple databases (MEDLINE, Embase, Cochrane CENTRAL, Scopus, Web of Science) without date restrictions.
Main Results:
- Twenty studies were identified, with 10 directly relevant to OMFS/dental applications.
- MOF demonstrated comparable sedation and superior patient preference over nitrous oxide in third molar surgery (p<0.05).
- Systematic reviews indicated high patient satisfaction (63%-98%) and no serious adverse events in outpatient settings at analgesic doses.
Conclusions:
- Evidence supports the clinical feasibility of MOF in OMFS, particularly for third molar surgery and acute oral pain.
- High-quality, OMFS-specific randomized controlled trials (RCTs) are currently lacking.
- The ongoing METODO trial (NCT06495372) is expected to provide pivotal data, with future research needed on OMFS-specific protocols and regulatory approvals.
Related Concept Videos
Inhalational Anesthetics: Overview
Parenteral Anesthetics: Overview
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Stages of General Anesthesia
Skeletal Muscle Relaxants: Therapeutic Uses
Local Anesthetics: Common Agents and Their Applications
Cocaine is an ester of benzoic acid and methylecgogine. It is used to anesthetize and vasoconstrict locally. Currently, it is used primarily for topical applications. It is beneficial for surgeries on the upper respiratory tract, providing anesthesia and shrinking the mucosa. Cocaine in the form of cocaine hydrochloride is...
